Deciphering the alternatively activated (M2) phenotype of macrophages in scleroderma

Experimental Dermatology

Volumn 24, Issue 8, 2015, Pages 576-578

  Manetti, Mirko ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alternative macrophage activation; Dermal fibrosis; Localized scleroderma; M2 macrophages; Systemic sclerosis

Indexed keywords

CELL POLARITY; HUMAN; LOCALIZED SCLERODERMA; MACROPHAGE ACTIVATION; NOTE; PATHOGENESIS; PHENOTYPE; POLARIZATION; SCLERODERMA; SKIN DEFECT; ANIMAL; ENZYMOLOGY; PHYSIOLOGY; SYSTEMIC SCLEROSIS;

BLEOMYCIN; N ACETYLGLUCOSAMINYLTRANSFERASE;

ANIMALS; BLEOMYCIN; HUMANS; N-ACETYLGLUCOSAMINYLTRANSFERASES; SCLERODERMA, SYSTEMIC;

EID: 84937971082     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12727     Document Type: Note

References (13)

1. Fett N. Clin Dermatol 2013: 31: 432-437.
2. Hunzelmann N, Krieg T. Exp Dermatol 2010: 19: 393-400.
3. Wynn T A, Ramalingam T R. Nat Med 2012: 18: 1028-1040.
4. Higashi-Kuwata N, Jinnin M, Makino T et al. Arthritis Res Ther 2010: 12: R128.
5. Higashi-Kuwata N, Makino T, Inoue Y et al. Exp Dermatol 2009: 18: 727-729.
6. Gordon S, Martinez F O. Immunity 2010: 32: 593-604.
7. Roca H, Varsos Z S, Sud S et al. J Biol Chem 2009: 284: 34342-34354.
8. Nakayama W, Jinnin M, Makino K et al. Rheumatol Int 2012: 32: 403-407.
9. Christmann R B, Sampaio-Barros P, Stifano G et al. Arthritis Rheumatol 2014: 66: 714-725.
10. Pechkovsky D V, Prasse A, Kollert F et al. Clin Immunol 2010: 137: 89-101.
11. Christmann R B, Hayes E, Pendergrass S et al. Arthritis Rheum 2011: 63: 1718-1728.
12. Kato A, Yutani M, Terao M et al. Exp Dermatol 2015: doi: 10.1111/exd.12730.
13. MacKinnon A C, Farnworth S L, Hodkinson P S et al. J Immunol 2008: 180: 2650-2658.